Costs associated with the use of multigene panel tests in three solid tumor types and the impact on insurance premiums supplementary materials

This study was funded by Genentech, Inc. D Sheinson, TM To and W Wong are employees of Genentech, Inc. and have Roche Stock. Y Liu is an employee of Genesis Research, which received funding from Genentech, Inc. in connection with this study. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. Medical writing support was provided by J Carthy and R Hornby of Oxford PharmaGenesis (Oxford, UK), and was funded by Genentech, Inc.